Accretion Pharmaceuticals IPO to Open on May 14
Accretion Pharmaceuticals has fixed the IPO price band at INR 96 to INR 101 per share.
The IPO of Gujarat-based Accretion Pharmaceuticals is set to open for subscription on Wednesday, May 14, 2025.
The company aims to raise INR 29.75 Cr through a fresh issue of 2.94 million equity shares.
There is no offer-for-sale (OFS) component in the issue.
Accretion Pharmaceuticals has fixed the IPO price band at INR 96 to INR 101 per share.
The minimum lot size for retail investors is 1,200 shares, requiring a minimum investment of INR 1,21,200. High-net-worth individuals (HNIs) will need at least INR 2,42,400 to apply for two lots.
The three-day subscription window will close on Friday, May 16, 2025. Additionally, the anchor investor bidding will take place on Tuesday, May 13.
Further, the basis of allotment is expected by Monday, May 19, and shares will list on the NSE Emerge platform tentatively on Wednesday, May 21.
Kfin Technologies is the registrar for the issue, while Jawa Capital Services is the sole book-running lead manager.
Stay tuned for more such updates on Digital Health News.
Stay tuned for more such updates on Digital Health News
